Antimalarial drug efficacy maps

Last update: 9 March 2017

These interactive maps provide a visual overview of therapeutic efficacy study results, according to malaria species, antimalarial treatment, year and geographic location.

Currently, two maps are available: one shows the results of studies of Plasmodium falciparum, while the other shows studies of P. vivax. Both maps show the percentage of patients with treatment failure.

The map of P. falciparum studies also provide the percentage of patients positive on day 3, which is an indicator of parasite susceptibility to the artemisinin component of an artemisinin-based combination therapy (ACT). For the map of P. vivax studies, the percentage of patients with confirmed resistance, as determined by the presence of adequate drug blood levels, is provided where available.

User's guide